The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 45 | — | 20.1x | Near average | |
Growth | 64 | — | 5.6% | Near average | |
Quality | 4 | -2057.1% | 7.6% | Below average | |
Safety | 39 | 0.7x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | 74 | — | — | Above average | |
Sentiment | 34 | — | — | Below average |
Cabaletta Bio, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Cabaletta Bio, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Cabaletta Bio stock shows remarkable stability in the average price target at $16.33 over the past thirty days, maintaining positive ratings (Buy/Overweight) from major institutions such as Jefferies and Guggenheim. However, the data reflects sharp Analyst Dispersion, with estimates ranging between $3 and $32, indicating a high state of uncertainty regarding the stock's fair value despite general optimism.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.